Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model

Neuroblastoma is a childhood malignancy and in the majority of patients, the primary tumor arises in one of the adrenal glands. Neuroblastoma cells highly express the disialoganglioside GD2, which is the primary target for the development of neuroblastoma immunotherapy. Anti-GD2 mAbs have shown clin...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Bijgaart, Renske J. E., Kroesen, Michiel, Brok, Ingrid C., Reijnen, Daphne, Wassink, Melissa, Boon, Louis, Hoogerbrugge, Peter M., Adema, Gosse J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781842/
https://www.ncbi.nlm.nih.gov/pubmed/33457098
http://dx.doi.org/10.1080/2162402X.2020.1817653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781842/
https://www.ncbi.nlm.nih.gov/pubmed/33457098
http://dx.doi.org/10.1080/2162402X.2020.1817653

Ejemplares similares